Heinrich Wieneke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heinrich Wieneke has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Bernhard Strohmer
Department of Cardiology, Salzburger Landeskliniken, Paracelsus Private Medical University, Salzburg, Austria
2 shared publications- Domenico Corrado
Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy
2 shared publications - Francisco Javier García Fernández
Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario de Burgos, Burgos, Spain
2 shared publications Hervé Le Marec
Department of Cardiology and Vascular Medicine, Hospital Guillaume et René Laennec, Nantes, France
2 shared publicationsJuan Gabriel Martinez
Department of Cardiology, Hospital General Universitario de Alicante, Spain
2 shared publicationsLauri Toivonen
Department of Cardiovascular Research, Meilahden Sairaala, Helsinki, Finland
2 shared publications
Latest Publications
- Open Access
- 18 September 2023
- Published by Wiley in Clinical Cardiology
- Vol. 47 (1)
Principles of artificial intelligence and its application in cardiovascular medicine
Artificial intelligence (AI) represents a rapidly developing field. Its use can improve diagnosis and therapy in many areas of medicine. Despite this enormous progress, many physicians perceive it as a black box and are skeptical about it. This review will present the basics of machine learning. Different classifications of artificial intelligence, such as supervised versus unsupervised and discriminative versus generative AI, are given. Analogies to human intelligence are discussed as far as algorithms are oriented toward it. In the second step, the most common models like random forest, k‐means clustering, convolutional neural network, and transformers will be presented in a way that the underlying idea can be understood. Corresponding medical applications in cardiovascular medicine will be named for all models, respectively. The overview is intended to show that the term artificial intelligence covers a wide range of different concepts. It should help physicians understand the principles of AI to make up one's minds about its application in cardiology. It should also enable them to evaluate results obtained with AI's help critically.
- 18 September 2023
- Published by Wiley in Clinical Cardiology
- Vol. 47 (1)
Open AccessPrinciples of artificial intelligence and its application in cardiovascular medicine
Artificial intelligence (AI) represents a rapidly developing field. Its use can improve diagnosis and therapy in many areas of medicine. Despite this enormous progress, many physicians perceive it as a black box and are skeptical about it. This review will present the basics of machine learning. Different classifications of artificial intelligence, such as supervised versus unsupervised and discriminative versus generative AI, are given. Analogies to human intelligence are discussed as far as algorithms are oriented toward it. In the second step, the most common models like random forest, k‐means clustering, convolutional neural network, and transformers will be presented in a way that the underlying idea can be understood. Corresponding medical applications in cardiovascular medicine will be named for all models, respectively. The overview is intended to show that the term artificial intelligence covers a wide range of different concepts. It should help physicians understand the principles of AI to make up one's minds about its application in cardiology. It should also enable them to evaluate results obtained with AI's help critically.
- Open Access
- 19 April 2022
- Published by Wiley in Clinical Cardiology
- Vol. 45 (6) , 657-663
A deep neural network using audio files for detection of aortic stenosis
Background: Although aortic stenosis (AS) is the most common valvular heart disease in the western world, many affected patients remain undiagnosed. Auscultation is a readily available screening tool for AS. However, it requires a high level of professional expertise.Hypothesis: An AI algorithm can detect AS using audio files with the same accuracy as experienced cardiologists.Methods: A deep neural network (DNN) was trained by preprocessed audio files of 100 patients with AS and 100 controls. The DNN's performance was evaluated with a test data set of 40 patients. The primary outcome measures were sensitivity, specificity, and F1‐score. Results of the DNN were compared with the performance of cardiologists, residents, and medical students.Results: Eighteen percent of patients without AS and 22% of patients with AS showed an additional moderate or severe mitral regurgitation. The DNN showed a sensitivity of 0.90 (0.81–0.99), a specificity of 1, and an F1‐score of 0.95 (0.89–1.0) for the detection of AS. In comparison, we calculated an F1‐score of 0.94 (0.86–1.0) for cardiologists, 0.88 (0.78–0.98) for residents, and 0.88 (0.78–0.98) for students.Conclusions: The present study shows that deep learning‐guided auscultation predicts significant AS with similar accuracy as cardiologists. The results of this pilot study suggest that AI‐assisted auscultation may help general practitioners without special cardiology training in daily practice.
- 19 April 2022
- Published by Wiley in Clinical Cardiology
- Vol. 45 (6) , 657-663
Open AccessA deep neural network using audio files for detection of aortic stenosis
Background: Although aortic stenosis (AS) is the most common valvular heart disease in the western world, many affected patients remain undiagnosed. Auscultation is a readily available screening tool for AS. However, it requires a high level of professional expertise.Hypothesis: An AI algorithm can detect AS using audio files with the same accuracy as experienced cardiologists.Methods: A deep neural network (DNN) was trained by preprocessed audio files of 100 patients with AS and 100 controls. The DNN's performance was evaluated with a test data set of 40 patients. The primary outcome measures were sensitivity, specificity, and F1‐score. Results of the DNN were compared with the performance of cardiologists, residents, and medical students.Results: Eighteen percent of patients without AS and 22% of patients with AS showed an additional moderate or severe mitral regurgitation. The DNN showed a sensitivity of 0.90 (0.81–0.99), a specificity of 1, and an F1‐score of 0.95 (0.89–1.0) for the detection of AS. In comparison, we calculated an F1‐score of 0.94 (0.86–1.0) for cardiologists, 0.88 (0.78–0.98) for residents, and 0.88 (0.78–0.98) for students.Conclusions: The present study shows that deep learning‐guided auscultation predicts significant AS with similar accuracy as cardiologists. The results of this pilot study suggest that AI‐assisted auscultation may help general practitioners without special cardiology training in daily practice.
- Open Access
- 25 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (11) , ytab336
A spear to the heart—the accidental discovery of a giant cement embolism in the right heart: a case report
Background: The incidence of recognized cardiopulmonary cement embolism in the context of percutaneous vertebroplasty varies between 0% and 23%. In most cases, only small fragments embolize in the pulmonary arteries or the right heart cavities. The latter can cause potential harm by right ventricular perforation. Case summary: A 57-year-old patient was admitted to our department of cardiology due to exertional dyspnoea and chest pain. In the course of further diagnostic tests, a huge cement embolus was accidentally discovered in the right ventricle. The unusual size and length and the threat of ventricular perforation make this case so unique. Discussion: Large cement embolisms in kyphoplasty settings are possible and associated with the risk of fulminant complications.
- 25 August 2021
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
- Vol. 5 (11) , ytab336
Open AccessA spear to the heart—the accidental discovery of a giant cement embolism in the right heart: a case report
Background: The incidence of recognized cardiopulmonary cement embolism in the context of percutaneous vertebroplasty varies between 0% and 23%. In most cases, only small fragments embolize in the pulmonary arteries or the right heart cavities. The latter can cause potential harm by right ventricular perforation. Case summary: A 57-year-old patient was admitted to our department of cardiology due to exertional dyspnoea and chest pain. In the course of further diagnostic tests, a huge cement embolus was accidentally discovered in the right ventricle. The unusual size and length and the threat of ventricular perforation make this case so unique. Discussion: Large cement embolisms in kyphoplasty settings are possible and associated with the risk of fulminant complications.
- Open Access
- 1 December 2016
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (12)
Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study
Background: Population‐based studies suggest that genetic factors contribute to sudden cardiac death ( SCD ). Methods and Results: In the first part of the present study (Diagnostic Data Influence on Disease Management and Relation of Genetic Polymorphisms to Ventricular Tachy‐arrhythmia in ICD Patients [DISCOVERY] trial) Cox regression was done to determine if 7 single‐nucleotide polymorphisms ( SNP s) in 3 genes coding G‐protein subunits ( GNB 3, GNAQ , GNAS ) were associated with ventricular tachyarrhythmia ( VT ) in 1145 patients receiving an implantable cardioverter‐defibrillator ( ICD ). In the second part of the study, SNP s significantly associated with VT were further investigated in 1335 subjects from the Oregon SUDS , a community‐based study analyzing causes of SCD . In the DISCOVERY trial, genotypes of 2 SNP s in the GNAS gene were nominally significant in the prospective screening and significantly associated with VT when viewed as recessive traits in post hoc analyses ( TT vs CC / CT in c.393C>T: HR 1.42 [ CI 1.11‐1.80], P =0.005; TT vs CC / CT in c.2273C>T: HR 1.57 [ CI 1.18‐2.09], P =0.002). TT genotype in either SNP was associated with a HR of 1.58 ( CI 1.26‐1.99) ( P =0.0001). In the Oregon SUDS cohort significant evidence for association with SCD was observed for GNAS c.393C>T under the additive ( P =0.039, OR =1.21 [ CI 1.05‐1.45]) and recessive ( P =0.01, OR =1.52 [ CI 1.10‐2.13]) genetic models. Conclusions: GNAS harbors 2 SNP s that were associated with an increased risk for VT in ICD patients, of which 1 was successfully replicated in a community‐based population of SCD cases. To the best of our knowledge, this is the first example of a gene variant identified by ICD VT monitoring as a surrogate parameter for SCD and also confirmed in the general population. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 00478933.
- 1 December 2016
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 5 (12)
Open AccessPolymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study
Background: Population‐based studies suggest that genetic factors contribute to sudden cardiac death ( SCD ). Methods and Results: In the first part of the present study (Diagnostic Data Influence on Disease Management and Relation of Genetic Polymorphisms to Ventricular Tachy‐arrhythmia in ICD Patients [DISCOVERY] trial) Cox regression was done to determine if 7 single‐nucleotide polymorphisms ( SNP s) in 3 genes coding G‐protein subunits ( GNB 3, GNAQ , GNAS ) were associated with ventricular tachyarrhythmia ( VT ) in 1145 patients receiving an implantable cardioverter‐defibrillator ( ICD ). In the second part of the study, SNP s significantly associated with VT were further investigated in 1335 subjects from the Oregon SUDS , a community‐based study analyzing causes of SCD . In the DISCOVERY trial, genotypes of 2 SNP s in the GNAS gene were nominally significant in the prospective screening and significantly associated with VT when viewed as recessive traits in post hoc analyses ( TT vs CC / CT in c.393C>T: HR 1.42 [ CI 1.11‐1.80], P =0.005; TT vs CC / CT in c.2273C>T: HR 1.57 [ CI 1.18‐2.09], P =0.002). TT genotype in either SNP was associated with a HR of 1.58 ( CI 1.26‐1.99) ( P =0.0001). In the Oregon SUDS cohort significant evidence for association with SCD was observed for GNAS c.393C>T under the additive ( P =0.039, OR =1.21 [ CI 1.05‐1.45]) and recessive ( P =0.01, OR =1.52 [ CI 1.10‐2.13]) genetic models. Conclusions: GNAS harbors 2 SNP s that were associated with an increased risk for VT in ICD patients, of which 1 was successfully replicated in a community‐based population of SCD cases. To the best of our knowledge, this is the first example of a gene variant identified by ICD VT monitoring as a surrogate parameter for SCD and also confirmed in the general population. Clinical Trial Registration: URL : http://www.clinicaltrials.gov . Unique identifier: NCT 00478933.
- Open Access
- 1 October 2012
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 15 (3) , 453-459
Leadless pacing using induction technology: impact of pulse shape and geometric factors on pacing efficiency
Leadless pacing can be done by transmitting energy by an alternating magnetic field from a subcutaneous transmitter unit (TU) to an endocardial receiver unit (RU). Safety and energy consumption are key issues that determine the clinical feasibility of this new technique. The aims of the study were (i) to evaluate the stimulation characteristics of the non-rectangular pacing pulses induced by the alternating magnetic field, (ii) to determine the extent and impact of RU movement caused by the beating heart, and (iii) to evaluate the influence of the relative position between TU and RU on pacing efficiency and energy consumption. In the first step pacing efficiency and energy consumption for predefined positions were determined by bench testing. Subsequently, in a goat at five different ventricular sites (three in the right ventricle, two in the left ventricle) pacing thresholds using non-rectangular induction pulses were compared with conventional pulses. Relative position, defined by parallel distance, radial distance, and angulation between TU and RU, were determined in vivo by X-ray and an inclination angle measurement system. Bench testing showed that by magnetic induction for every alignment between TU and RU appropriate pulses can be produced up to a distance of 100 mm. In the animal experiment pacing thresholds were similar for non-rectangular pulses as compared with conventional pulse shapes. In all five positions with distances between 62 and 102 mm effective pacing was obtained in vivo. Variations in distance, displacement and angle caused by the beating heart did not cause loss of capture. At pacing threshold energy consumptions between 0.28 and 5.36 mJ were measured. Major determinants of energy consumption were distance and pacing threshold. For any given RU position up to a distance of 100 mm reliable pacing using induction can be obtained. In anatomically crucial distances, up to 60 mm energy consumption is within a reasonable range.
- 1 October 2012
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 15 (3) , 453-459
Open AccessLeadless pacing using induction technology: impact of pulse shape and geometric factors on pacing efficiency
Leadless pacing can be done by transmitting energy by an alternating magnetic field from a subcutaneous transmitter unit (TU) to an endocardial receiver unit (RU). Safety and energy consumption are key issues that determine the clinical feasibility of this new technique. The aims of the study were (i) to evaluate the stimulation characteristics of the non-rectangular pacing pulses induced by the alternating magnetic field, (ii) to determine the extent and impact of RU movement caused by the beating heart, and (iii) to evaluate the influence of the relative position between TU and RU on pacing efficiency and energy consumption. In the first step pacing efficiency and energy consumption for predefined positions were determined by bench testing. Subsequently, in a goat at five different ventricular sites (three in the right ventricle, two in the left ventricle) pacing thresholds using non-rectangular induction pulses were compared with conventional pulses. Relative position, defined by parallel distance, radial distance, and angulation between TU and RU, were determined in vivo by X-ray and an inclination angle measurement system. Bench testing showed that by magnetic induction for every alignment between TU and RU appropriate pulses can be produced up to a distance of 100 mm. In the animal experiment pacing thresholds were similar for non-rectangular pulses as compared with conventional pulse shapes. In all five positions with distances between 62 and 102 mm effective pacing was obtained in vivo. Variations in distance, displacement and angle caused by the beating heart did not cause loss of capture. At pacing threshold energy consumptions between 0.28 and 5.36 mJ were measured. Major determinants of energy consumption were distance and pacing threshold. For any given RU position up to a distance of 100 mm reliable pacing using induction can be obtained. In anatomically crucial distances, up to 60 mm energy consumption is within a reasonable range.
- Open Access
- 5 February 2010
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (3) , 424-429
Polymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study
Implantable cardioverter-defibrillator (ICD) therapy is effective in primary and secondary prevention for patients who are at high risk of sudden cardiac death. However, the current risk stratification of patients who may benefit from this therapy is unsatisfactory. Single nucleotide polymorphisms (SNPs) are DNA sequence variations occurring when a single nucleotide in the genome differs among members of a species. A novel concept has emerged being that these common genetic variations might modify the susceptibility of a certain population to specific diseases. Thus, genetic factors may also modulate the risk for arrhythmias and sudden cardiac death, and identification of common variants could help to better identify patients at risk. The DISCOVERY study is an interventional, longitudinal, prospective, multi-centre diagnostic study that will enrol 1287 patients in ∼80 European centres. In the genetic part of the DISCOVERY study, candidate gene polymorphisms involved in coding of the G-protein subunits will be correlated with the occurrence of ventricular arrhythmias in patients receiving an ICD for primary prevention. Furthermore, in order to search for additional sequence variants contributing to ventricular arrhythmias, a genome-wide association study will be conducted if sufficient a priori evidence can be gathered. In the second part of the study, associations of SNPs with ventricular arrhythmias will be sought and a search for potential new biological arrhythmic pathways will be investigated. As it is a diagnostic study, DISCOVERY will also investigate the impact of long-term device diagnostic data on the management of patients suffering from chronic cardiac disease as well as medical decisions made regarding their treatment.
- 5 February 2010
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 12 (3) , 424-429
Open AccessPolymorphisms associated with ventricular tachyarrhythmias: rationale, design, and endpoints of the 'diagnostic data influence on disease management and relation of genomics to ventricular tachyarrhythmias in implantable cardioverter/defibrillator patients (DISCOVERY)' study
Implantable cardioverter-defibrillator (ICD) therapy is effective in primary and secondary prevention for patients who are at high risk of sudden cardiac death. However, the current risk stratification of patients who may benefit from this therapy is unsatisfactory. Single nucleotide polymorphisms (SNPs) are DNA sequence variations occurring when a single nucleotide in the genome differs among members of a species. A novel concept has emerged being that these common genetic variations might modify the susceptibility of a certain population to specific diseases. Thus, genetic factors may also modulate the risk for arrhythmias and sudden cardiac death, and identification of common variants could help to better identify patients at risk. The DISCOVERY study is an interventional, longitudinal, prospective, multi-centre diagnostic study that will enrol 1287 patients in ∼80 European centres. In the genetic part of the DISCOVERY study, candidate gene polymorphisms involved in coding of the G-protein subunits will be correlated with the occurrence of ventricular arrhythmias in patients receiving an ICD for primary prevention. Furthermore, in order to search for additional sequence variants contributing to ventricular arrhythmias, a genome-wide association study will be conducted if sufficient a priori evidence can be gathered. In the second part of the study, associations of SNPs with ventricular arrhythmias will be sought and a search for potential new biological arrhythmic pathways will be investigated. As it is a diagnostic study, DISCOVERY will also investigate the impact of long-term device diagnostic data on the management of patients suffering from chronic cardiac disease as well as medical decisions made regarding their treatment.
- 31 July 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (1) , 61-66
β-Blocker Prophylaxis for Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Sympathovagal Imbalance
- 31 July 2007
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 84 (1) , 61-66
β-Blocker Prophylaxis for Atrial Fibrillation After Coronary Artery Bypass Grafting in Patients With Sympathovagal Imbalance
- 1 September 2005
- Published by Springer Nature in Herzschrittmachertherapie + Elektrophysiologie
- Vol. 16 (3) , 165-175
Das Herz Handy®—ein neues telemedizinisches Servicekonzept für Herzpatienten
Telemedicine is a new milestone for the health care system in the care of patients with heart disease. New technologies and the possibilities of fast data transmission have enabled this step forward. The Cardiophone® offers a new telemonitoring Service Concept, which is available 24 hours a day. The patient is by the aid of the Cardiophone® connected with the Medical Service Center at just the press of a button, can record and transmit an ECG and can be localized by the incorporated GPS. We report about our experiences with 363 patients over 3 years. Out of 5064 patient contacts associated with 7561 calls, 559 emergency contacts occurred. From the initial main complaints, working diagnoses were established. The final confirmed diagnoses were arrhythmias (27.8%), coronary heart disease (25.9%), psychovegetative syndrome (12.7%), backbone pain (6.2%), gastrointestinal syndrome (3.6%), others (1.8%), and exclusion diagnosis (19.9%). Ten myocardial infarctions were diagnosed, of whom 3 were confirmed; the other 7 were treated as stabile angina pectoris. Overall 823 ECG were transmitted, in average 1.6 ECGs per emergency contact. In 131 ECGs changes of the ST-segment or T-wave could be documented; 26 patients showed a pacemaker ECG. Atrial and ventricular arrhythmias as well as conduction disturbances were seen. The majority of emergency contacts (n=477, 85.3%) were successfully managed by the Service Center. In 38 emergency contacts (6.8%) admission to hospital was recommended; in 4 cases (0.7%) an ambulance was activated via the local dispatcher by the Service Center and in 29 cases (5.2%) the emergency ambulance. Die Telemedizin stellt einen neuen Baustein in der Betreuung von Herzpatienten für das Gesundheitssystem dar. Neue Technologien und die Möglichkeit der schnellen Datenübertragung haben diesen Schritt ermöglicht. Mit dem Herz Handy® wurde ein neues telemonitorisches Service-Konzept etabliert, das dem Patienten rund um die Uhr zur Verfügung steht. Der Patient ist mit dem Herz Handy® an das Medizinische Service-Center per Notfalltaste angebunden, kann sein EKG ableiten und übertragen und über das integrierte GPS-System geortet wer- den.Wir berichten über unsere Erfahrungen mit 363 Patienten über einen Beobachtungszeitraum von drei Jahren. Von den 5064 Patientenkontakten mit 7561 Anrufen waren 559 Notfallkontakte. Aus den Hauptbeschwerden wurden Arbeitsdiagnosen abgeleitet. Die resultierenden Enddiagnosen waren Herzrhythmusstörungen (27,8%), KHK (25,9%), Psychovegetatives Syndrom (12,7%), Wirbelsäulen-Syndrom (6,2%), Gastroinestinales Syndrom (3,6%), Sonstiges (1,8%) oder Ausschluss-Diagnosen (19,9%). Zehn akute Myokardinfarkte wurden diagnostiziert, von denen 3 bestätigt wurden; die anderen 7 wurden als stabile Angina pectoris weiter behandelt. Es wurden 823 Elektrokardiogramme übertragen, im Mittel 1,6 EKGs pro Notfallkontakt. Bei 131 EKGs zeigten sich Veränderungen der STStrecke oder T-Welle; 26 Patienten hatten einen Herzschrittmacher. Atriale und ventrikuläre Rhytmusstörungen sowie Überleitungsstörungen konnten dokumentiert werden. Die Mehrzahl der Notfallkontakte (n=477, 85,3%) konnten im Service-Center erfolgreich bearbeitet werden. Bei 38 Notfallkontakten (6,8%) wurde die Einweisung in das nächste Krankenhaus empfohlen; in 4 Fällen (0,7%) wurde über die zuständige örtliche Rettungsleitstelle der Rettungswagen und in 29 Fällen (5,2%) der Notarztwagen über das Service-Center angefordert.
- 1 September 2005
- Published by Springer Nature in Herzschrittmachertherapie + Elektrophysiologie
- Vol. 16 (3) , 165-175
Das Herz Handy®—ein neues telemedizinisches Servicekonzept für Herzpatienten
Telemedicine is a new milestone for the health care system in the care of patients with heart disease. New technologies and the possibilities of fast data transmission have enabled this step forward. The Cardiophone® offers a new telemonitoring Service Concept, which is available 24 hours a day. The patient is by the aid of the Cardiophone® connected with the Medical Service Center at just the press of a button, can record and transmit an ECG and can be localized by the incorporated GPS. We report about our experiences with 363 patients over 3 years. Out of 5064 patient contacts associated with 7561 calls, 559 emergency contacts occurred. From the initial main complaints, working diagnoses were established. The final confirmed diagnoses were arrhythmias (27.8%), coronary heart disease (25.9%), psychovegetative syndrome (12.7%), backbone pain (6.2%), gastrointestinal syndrome (3.6%), others (1.8%), and exclusion diagnosis (19.9%). Ten myocardial infarctions were diagnosed, of whom 3 were confirmed; the other 7 were treated as stabile angina pectoris. Overall 823 ECG were transmitted, in average 1.6 ECGs per emergency contact. In 131 ECGs changes of the ST-segment or T-wave could be documented; 26 patients showed a pacemaker ECG. Atrial and ventricular arrhythmias as well as conduction disturbances were seen. The majority of emergency contacts (n=477, 85.3%) were successfully managed by the Service Center. In 38 emergency contacts (6.8%) admission to hospital was recommended; in 4 cases (0.7%) an ambulance was activated via the local dispatcher by the Service Center and in 29 cases (5.2%) the emergency ambulance. Die Telemedizin stellt einen neuen Baustein in der Betreuung von Herzpatienten für das Gesundheitssystem dar. Neue Technologien und die Möglichkeit der schnellen Datenübertragung haben diesen Schritt ermöglicht. Mit dem Herz Handy® wurde ein neues telemonitorisches Service-Konzept etabliert, das dem Patienten rund um die Uhr zur Verfügung steht. Der Patient ist mit dem Herz Handy® an das Medizinische Service-Center per Notfalltaste angebunden, kann sein EKG ableiten und übertragen und über das integrierte GPS-System geortet wer- den.Wir berichten über unsere Erfahrungen mit 363 Patienten über einen Beobachtungszeitraum von drei Jahren. Von den 5064 Patientenkontakten mit 7561 Anrufen waren 559 Notfallkontakte. Aus den Hauptbeschwerden wurden Arbeitsdiagnosen abgeleitet. Die resultierenden Enddiagnosen waren Herzrhythmusstörungen (27,8%), KHK (25,9%), Psychovegetatives Syndrom (12,7%), Wirbelsäulen-Syndrom (6,2%), Gastroinestinales Syndrom (3,6%), Sonstiges (1,8%) oder Ausschluss-Diagnosen (19,9%). Zehn akute Myokardinfarkte wurden diagnostiziert, von denen 3 bestätigt wurden; die anderen 7 wurden als stabile Angina pectoris weiter behandelt. Es wurden 823 Elektrokardiogramme übertragen, im Mittel 1,6 EKGs pro Notfallkontakt. Bei 131 EKGs zeigten sich Veränderungen der STStrecke oder T-Welle; 26 Patienten hatten einen Herzschrittmacher. Atriale und ventrikuläre Rhytmusstörungen sowie Überleitungsstörungen konnten dokumentiert werden. Die Mehrzahl der Notfallkontakte (n=477, 85,3%) konnten im Service-Center erfolgreich bearbeitet werden. Bei 38 Notfallkontakten (6,8%) wurde die Einweisung in das nächste Krankenhaus empfohlen; in 4 Fällen (0,7%) wurde über die zuständige örtliche Rettungsleitstelle der Rettungswagen und in 29 Fällen (5,2%) der Notarztwagen über das Service-Center angefordert.